Insilico Medicine is hosting a multi-center Phase III clinical trial for its drug Rentosertib at leading hospitals.
2 reports, 1 independent
Updated Sep 10
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insilico Medicine is hosting a multi-center Phase III clinical trial for its drug Rentosertib at leading hospitals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Insilico Medicine
American biotechnology company
Nothing else this week.